NCT03209635View on ClinicalTrials.gov

Weissella Cibaria JW15 Consumption and NK Cell Activity

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 1, 2016

Primary Completion Date

March 20, 2017

Study Completion Date

March 20, 2017

Conditions
Immune Function
Interventions
DIETARY_SUPPLEMENT

Placebo

4 capsules (300 mg/capsule) containing 52% crystalline cellulose and 46% lactose in identical-looking with test product

DIETARY_SUPPLEMENT

Probiotic

4 capsules (300 mg/capsule) containing each capsule 1.0 x 10\^10 colony-forming units (cfu) of Weissella cibaria JW15, twice a day

All Listed Sponsors
lead

Yonsei University

OTHER

NCT03209635 - Weissella Cibaria JW15 Consumption and NK Cell Activity | Biotech Hunter | Biotech Hunter